Latest issue of Hampshire & IOW Medicines Optimisation Bulletin

The latest bulletin contains information on the following:

1. Class 1 medicine recall of Emerade 500 micrograms and Emerade 300 micrograms auto-injectors, due to the potential for device failure
2. Isotretinoin (Roaccutane▼): new safety measures to be introduced in the coming months, including additional oversight on initiation of treatment for patients under 18 years
3. Nitrofurantoin: reminder of the risks of pulmonary and hepatic adverse drug reactions
4. ICB Guidelines for the treatment of Dry Eye Syndrome in Primary Care
5. Continuous Glucose Monitoring (CGM) for Diabetes in Adults
6. Pharmacotherapy for chronic kidney disease (CKD) in primary care
7. AHSN Lipid Management Pathways
8. COVID-19 the green book, chapter 14a update
9. Influenza Season 2022/23: ending the prescribing and supply of antiviral medicines in primary care
10. Diabetes (type 1 and type 2) in children and young people: diagnosis and management – updated guidance (NG18)

Download the bulletin here for more information and links:

• https://cpsc.franktesting.co.uk/download_file/view/4057/2772